3/A//SEC Filing
Pillar Invest Corp 3/A
Accession 0000899243-23-017444
CIK 0000861838other
Filed
Jul 18, 8:00 PM ET
Accepted
Jul 19, 4:05 PM ET
Size
18.1 KB
Accession
0000899243-23-017444
Insider Transaction Report
Form 3/AAmended
Aceragen, Inc.ACGN
Umari Abude
10% Owner
Holdings
- 135,540(indirect: By Pillar Pharmaceuticals 6, L.P.)
Common Stock
- 143,747(indirect: By Abude Umari)
Common Stock
- 355,247(indirect: By Foundation)
Common Stock
- 1,547(indirect: By Youssef El Zein)
Common Stock
- (indirect: By Foundation)
Warrants
Exercise: $0.01From: 2020-07-13Exp: 2023-07-13→ Common Stock (162,601 underlying) - (indirect: By Pillar Pharmaceuticals 6, L.P.)
Warrants
Exercise: $0.01From: 2020-12-11Exp: 2023-12-11→ Common Stock (45,114 underlying) - (indirect: By Foundation)
Warrants
Exercise: $0.01From: 2020-12-11Exp: 2023-12-11→ Common Stock (35,687 underlying)
ZEIN YOUSSEF EL
Director
Holdings
- 355,247(indirect: By Foundation)
Common Stock
- 135,540(indirect: By Pillar Pharmaceuticals 6, L.P.)
Common Stock
- 1,547(indirect: By Youssef El Zein)
Common Stock
- (indirect: By Foundation)
Warrants
Exercise: $0.01From: 2020-12-11Exp: 2023-12-11→ Common Stock (35,687 underlying) - (indirect: By Pillar Pharmaceuticals 6, L.P.)
Warrants
Exercise: $0.01From: 2020-12-11Exp: 2023-12-11→ Common Stock (45,114 underlying) - (indirect: By Foundation)
Warrants
Exercise: $0.01From: 2020-07-13Exp: 2023-07-13→ Common Stock (162,601 underlying) - 143,747(indirect: By Abude Umari)
Common Stock
Pillar Invest Corp
Director10% Owner
Holdings
- (indirect: By Foundation)
Warrants
Exercise: $0.01From: 2020-07-13Exp: 2023-07-13→ Common Stock (162,601 underlying) - 135,540(indirect: By Pillar Pharmaceuticals 6, L.P.)
Common Stock
- 143,747(indirect: By Abude Umari)
Common Stock
- (indirect: By Pillar Pharmaceuticals 6, L.P.)
Warrants
Exercise: $0.01From: 2020-12-11Exp: 2023-12-11→ Common Stock (45,114 underlying) - 355,247(indirect: By Foundation)
Common Stock
- 1,547(indirect: By Youssef El Zein)
Common Stock
- (indirect: By Foundation)
Warrants
Exercise: $0.01From: 2020-12-11Exp: 2023-12-11→ Common Stock (35,687 underlying)
Pillar Partners Foundation, L.P.
10% Owner
Holdings
- 143,747(indirect: By Abude Umari)
Common Stock
- (indirect: By Foundation)
Warrants
Exercise: $0.01From: 2020-07-13Exp: 2023-07-13→ Common Stock (162,601 underlying) - (indirect: By Pillar Pharmaceuticals 6, L.P.)
Warrants
Exercise: $0.01From: 2020-12-11Exp: 2023-12-11→ Common Stock (45,114 underlying) - 355,247(indirect: By Foundation)
Common Stock
- 135,540(indirect: By Pillar Pharmaceuticals 6, L.P.)
Common Stock
- 1,547(indirect: By Youssef El Zein)
Common Stock
- (indirect: By Foundation)
Warrants
Exercise: $0.01From: 2020-12-11Exp: 2023-12-11→ Common Stock (35,687 underlying)
Pillar Pharmaceuticals 6, L.P.
10% Owner
Holdings
- (indirect: By Foundation)
Warrants
Exercise: $0.01From: 2020-07-13Exp: 2023-07-13→ Common Stock (162,601 underlying) - 1,547(indirect: By Youssef El Zein)
Common Stock
- 143,747(indirect: By Abude Umari)
Common Stock
- 355,247(indirect: By Foundation)
Common Stock
- 135,540(indirect: By Pillar Pharmaceuticals 6, L.P.)
Common Stock
- (indirect: By Foundation)
Warrants
Exercise: $0.01From: 2020-12-11Exp: 2023-12-11→ Common Stock (35,687 underlying) - (indirect: By Pillar Pharmaceuticals 6, L.P.)
Warrants
Exercise: $0.01From: 2020-12-11Exp: 2023-12-11→ Common Stock (45,114 underlying)
Footnotes (2)
- [F1]Pillar Invest Corporation ("Pillar GP") is the general partner of Pillar Pharmaceuticals 6, L.P. ("Pillar 6") and Pillar Partners Foundation, L.P. ("Pillar Partners", together with Pillar GP and Pillar 6, the "Pillar Funds"). Youssef El Zein and Abude Umari are directors of Pillar GP. Each of Pillar GP, Mr. El Zein and Mr. Umari disclaims Section 16 beneficial ownership of the securities beneficially owned by the Pillar Funds and this report shall not be deemed an admission that any of Pillar GP, Mr. El Zein or Mr. Umari is the Section 16 beneficial owner of any such securities, except to the extent of its or his pecuniary interest therein, if any, by virtue of its or his ownership interest in the Pillar Funds or Pillar GP, as applicable.
- [F2]The warrants are exercisable subject to a beneficial ownership blocker provision that prevents the holder from exercising the warrants if such exercise would result in the holder beneficially owning more than 19.99% of the Issuer's Common Stock outstanding following such exercise.
Documents
Issuer
Aceragen, Inc.
CIK 0000861838
Entity typeother
IncorporatedCayman Islands
Related Parties
1- filerCIK 0001534428
Filing Metadata
- Form type
- 3/A
- Filed
- Jul 18, 8:00 PM ET
- Accepted
- Jul 19, 4:05 PM ET
- Size
- 18.1 KB